Literature DB >> 25963842

Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.

Rami Elshazli1, Ahmad Settin2.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a common autoimmune disease with a complex genetic background. The genes encoding protein tyrosine phosphatase non-receptor type 22 (PTPN22) and signal transducer and activator of transcription 4 (STAT4) have been reported to be associated with RA in several ethnic populations.
OBJECTIVES: This work aims to assess the association between PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with RA susceptibility through an updated meta-analysis of available case-control studies.
METHODS: A literature search of all relevant studies published from January 2007 up to December 2014 was conducted using Pubmed and Science Direct databases. The observed studies that were related to an association between PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with RA susceptibility were identified. Meta-analysis of the pooled and stratified data was done and assessed using varied genetic models.
RESULTS: Thirty-seven case-control studies with a total of 47 comparisons (29 for PTPN22 rs2476601 polymorphism and 18 for STAT4 rs7574865 polymorphism) met our inclusion criteria. The meta-analysis showed an association between PTPN22 T allele, CT+TT and TT genotypes with RA susceptibility. Furthermore, The meta-analysis showed an association between STAT4 T allele, GT+TT and TT genotypes with RA susceptibility. Stratification of RA patients according to ethnic groups showed that PTPN22 T allele, CT+TT genotypes, STAT4 T allele and STAT4 GT+TT were significantly associated with RA in European, Asian, African subjects, while PTPN22 TT genotype was significantly associated with RA in European but not in Asian and African subjects and STAT4 TT genotype was significantly associated with RA in European and Asian but not in African subject. A subgroup analysis according to the presence or absence of rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies revealed that the association between PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with RA susceptibility may not be dependent on RF and anti-CCP antibodies.
CONCLUSIONS: Our meta-analysis demonstrated that PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms confers susceptibility to RA in total subjects and in major ethnic groups. The association may not be dependent on RF and anti-CCP antibodies.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Anti-CCP; Meta-analysis; PTPN22; Polymorphism; RF; Rheumatoid arthritis; STAT4

Mesh:

Substances:

Year:  2015        PMID: 25963842     DOI: 10.1016/j.imbio.2015.04.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

1.  STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population.

Authors:  Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez; Raquel Rocío Hernández-Pacheco; América Del Carmen Castro-Zambrano; Liliana Ortiz-Martínez; José Francisco Zambrano-Zaragoza
Journal:  Clin Rheumatol       Date:  2016-05-28       Impact factor: 2.980

2.  Dense Genotyping of Immune-Related Regions Identifies Loci for Rheumatoid Arthritis Risk and Damage in African Americans.

Authors:  Maria I Danila; Vincent Albert Laufer; Richard J Reynolds; Qi Yan; Nianjun Liu; Peter K Gregersen; Annette Lee; Marlena Kern; Carl D Langefeld; Donna K Arnett; S Louis Bridges
Journal:  Mol Med       Date:  2017-06-29       Impact factor: 6.354

3.  The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Authors:  J F Mendoza Rincón; D López Cano; S Jiménez Morales; M L Rivas Jiménez; R E Barbosa Cobos; J Ramírez Bello
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

4.  Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis.

Authors:  C Ciccacci; P Conigliaro; C Perricone; S Rufini; P Triggianese; C Politi; G Novelli; R Perricone; P Borgiani
Journal:  Clin Exp Immunol       Date:  2016-08-02       Impact factor: 4.330

5.  Genetic polymorphisms of IL-17A rs2275913, rs3748067 and IL-17F rs763780 in gastric cancer risk: evidence from 8124 cases and 9873 controls.

Authors:  Rami M Elshazli; Doaa O Salman; Maha M Kamel; Eman A Toraih; Manal S Fawzy
Journal:  Mol Biol Rep       Date:  2018-06-02       Impact factor: 2.316

6.  Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis.

Authors:  Paola Conigliaro; Cinzia Ciccacci; Cristina Politi; Paola Triggianese; Sara Rufini; Barbara Kroegler; Carlo Perricone; Andrea Latini; Giuseppe Novelli; Paola Borgiani; Roberto Perricone
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

7.  Single-cell expression and Mendelian randomization analyses identify blood genes associated with lifespan and chronic diseases.

Authors:  Arnaud Chignon; Valentin Bon-Baret; Marie-Chloé Boulanger; Zhonglin Li; Deborah Argaud; Yohan Bossé; Sébastien Thériault; Benoit J Arsenault; Patrick Mathieu
Journal:  Commun Biol       Date:  2020-05-01

8.  A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases.

Authors:  Muhammad Muaaz Aslam; Fazal Jalil; Peter John; Kang-Hsien Fan; Attya Bhatti; Eleanor Feingold; F Yesim Demirci; M Ilyas Kamboh
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

Review 9.  Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.

Authors:  Adrianos Nezos; Clio P Mavragani
Journal:  J Immunol Res       Date:  2015-10-15       Impact factor: 4.818

10.  rs2476601 in PTPN22 gene in rheumatoid arthritis and periodontitis-a possible interface?

Authors:  Susanne Schulz; Pauline Zimmer; Natalie Pütz; Elisa Jurianz; Hans-Günter Schaller; Stefan Reichert
Journal:  J Transl Med       Date:  2020-10-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.